Prothena Corporation plc (PRTA)
USD 10.29
(-5.25%)
USD 10.29
(-5.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -129.2 Million USD | 75.89% |
| 2022 | 47.16 Million USD | -60.13% |
| 2021 | 118.29 Million USD | 259.79% |
| 2020 | -74.03 Million USD | -48.0% |
| 2019 | -50.02 Million USD | 50.09% |
| 2018 | -100.22 Million USD | 6.35% |
| 2017 | -107.02 Million USD | 9.67% |
| 2016 | -118.47 Million USD | -108.47% |
| 2015 | -56.83 Million USD | -558.25% |
| 2014 | 12.4 Million USD | 148.87% |
| 2013 | -25.37 Million USD | 19.39% |
| 2012 | -31.48 Million USD | -6309.27% |
| 2011 | 507 Thousand USD | -59.21% |
| 2010 | 1.24 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 131.12 Million USD | 9001.31% |
| 2024 Q1 | -837 Thousand USD | 94.01% |
| 2023 Q1 | 410 Thousand USD | -99.15% |
| 2023 Q3 | 82.55 Million USD | 3621.96% |
| 2023 FY | 82.95 Million USD | 75.89% |
| 2023 Q2 | 2.21 Million USD | 440.98% |
| 2023 Q4 | -13.96 Million USD | -116.92% |
| 2022 Q3 | -34.16 Million USD | -12.92% |
| 2022 Q4 | 48.19 Million USD | 241.06% |
| 2022 FY | 47.16 Million USD | -60.13% |
| 2022 Q1 | -26.1 Million USD | -25.01% |
| 2022 Q2 | -30.25 Million USD | -15.89% |
| 2021 Q4 | -20.88 Million USD | -117.24% |
| 2021 FY | 118.29 Million USD | 259.79% |
| 2021 Q1 | -20.98 Million USD | -2.86% |
| 2021 Q2 | 38.98 Million USD | 285.77% |
| 2021 Q3 | 121.18 Million USD | 210.87% |
| 2020 FY | -74.03 Million USD | -48.0% |
| 2020 Q1 | -15.1 Million USD | 0.71% |
| 2020 Q2 | -17.07 Million USD | -13.03% |
| 2020 Q3 | -21.44 Million USD | -25.6% |
| 2020 Q4 | -20.4 Million USD | 4.89% |
| 2019 Q4 | -15.21 Million USD | -23.89% |
| 2019 Q2 | -9.41 Million USD | 28.18% |
| 2019 FY | -50.02 Million USD | 50.09% |
| 2019 Q1 | -13.11 Million USD | 19.65% |
| 2019 Q3 | -12.28 Million USD | -30.43% |
| 2018 Q1 | -34.47 Million USD | -3.62% |
| 2018 Q4 | -16.31 Million USD | 10.65% |
| 2018 FY | -100.22 Million USD | 6.35% |
| 2018 Q3 | -18.26 Million USD | 41.42% |
| 2018 Q2 | -31.17 Million USD | 9.59% |
| 2017 Q3 | -41.09 Million USD | -469.2% |
| 2017 FY | -107.02 Million USD | 9.67% |
| 2017 Q4 | -33.27 Million USD | 19.04% |
| 2017 Q1 | -25.43 Million USD | 35.88% |
| 2017 Q2 | -7.22 Million USD | 71.62% |
| 2016 Q1 | -20.22 Million USD | -15.04% |
| 2016 FY | -118.47 Million USD | -108.47% |
| 2016 Q4 | -39.67 Million USD | -49.42% |
| 2016 Q3 | -26.55 Million USD | 17.09% |
| 2016 Q2 | -32.02 Million USD | -58.33% |
| 2015 Q4 | -17.58 Million USD | -4.94% |
| 2015 Q2 | -12.51 Million USD | -25.38% |
| 2015 Q3 | -16.75 Million USD | -33.91% |
| 2015 Q1 | -9.98 Million USD | -23.3% |
| 2015 FY | -56.83 Million USD | -558.25% |
| 2014 FY | 12.4 Million USD | 148.87% |
| 2014 Q4 | -8.09 Million USD | 9.08% |
| 2014 Q3 | -8.9 Million USD | -236.83% |
| 2014 Q1 | 22.89 Million USD | 521.35% |
| 2014 Q2 | 6.5 Million USD | -71.58% |
| 2013 Q4 | -5.43 Million USD | 12.04% |
| 2013 FY | -25.37 Million USD | 19.39% |
| 2013 Q1 | -5.78 Million USD | 37.5% |
| 2013 Q2 | -7.98 Million USD | -37.92% |
| 2013 Q3 | -6.17 Million USD | 22.59% |
| 2012 Q3 | -6.58 Million USD | -996.05% |
| 2012 Q2 | 735 Thousand USD | 81.93% |
| 2012 FY | -31.48 Million USD | -6309.27% |
| 2012 Q1 | 404 Thousand USD | 0.0% |
| 2012 Q4 | -9.25 Million USD | -40.57% |
| 2011 FY | 507 Thousand USD | -59.21% |
| 2010 FY | 1.24 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 439.779% |
| Alkermes plc | 1.37 Billion USD | 109.399% |
| Agenus Inc. | 139.61 Million USD | 192.541% |
| Aptorum Group Limited | -1.11 Million USD | -11490.777% |
| Ardelyx, Inc. | 106.66 Million USD | 221.132% |
| Dyadic International, Inc. | 922.95 Thousand USD | 14098.594% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 713.461% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -73795.438% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -867.229% |
| Novavax, Inc. | 639.93 Million USD | 120.19% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -175.841% |
| Pyxis Oncology, Inc. | -2 Million USD | -6360.05% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -24902.806% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 778.47% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -292289.336% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -24416.319% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -31.546% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 16209.85% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -157462.195% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 195.514% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1741.481% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -33.266% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 108.512% |
| AlloVir, Inc. | -398 Thousand USD | -32362.563% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 153.669% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 30571.934% |
| Bicycle Therapeutics plc | -129.52 Million USD | 0.246% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 107767.5% |
| ChromaDex Corporation | 50.78 Million USD | 354.433% |
| Chimerix, Inc. | 324 Thousand USD | 39976.852% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -314.535% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -66.5% |
| CRISPR Therapeutics AG | 240.95 Million USD | 153.62% |
| Precision BioSciences, Inc. | 40.47 Million USD | 419.236% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -31.619% |
| Fortress Biotech, Inc. | 57.85 Million USD | 323.326% |
| Fortress Biotech, Inc. | 57.85 Million USD | 323.326% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 879.399% |
| ImmuCell Corporation | 4.39 Million USD | 3038.868% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -21.746% |
| Immix Biopharma, Inc. | -5468.00 USD | -2362756.62% |
| Incyte Corporation | 3.44 Billion USD | 103.755% |
| Innoviva, Inc. | 261.06 Million USD | 149.49% |
| IO Biotech, Inc. | -756 Thousand USD | -16990.079% |
| Jaguar Health, Inc. | 7.72 Million USD | 1772.721% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -19357.982% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 207.89% |
| ContextLogic Inc. | 59 Million USD | 318.985% |
| MiMedx Group, Inc. | 266.84 Million USD | 148.418% |
| MEI Pharma, Inc. | 49.32 Million USD | 361.928% |
| NextCure, Inc. | -3.68 Million USD | -3407.085% |
| Onconetix, Inc. | -1.12 Million USD | -11362.474% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -346.013% |
| Opthea Limited | 21.72 Thousand USD | 594948.066% |
| Psyence Biomedical Ltd. | -240.00 USD | -53833650.0% |
| Vaxcyte, Inc. | -75 Million USD | -72.268% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -225279.409% |
| Precigen, Inc. | 106 Thousand USD | 121987.736% |
| Pharming Group N.V. | 220.1 Million USD | 158.7% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 25187.573% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 12904.856% |
| PureTech Health plc | -1.6 Million USD | -7959.95% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 217.699% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 28.779% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -185.055% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -487.625% |
| Acelyrin, Inc. | -115 Thousand USD | -112248.696% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1285354.184% |
| Summit Therapeutics Inc. | -2.05 Million USD | -6202.488% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -22527.145% |
| Senti Biosciences, Inc. | -2.68 Million USD | -4715.542% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 3289.361% |
| Elevation Oncology, Inc. | -39 Thousand USD | -331184.615% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -2592.81% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -3177.51% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 543.548% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 26148.589% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -234810.909% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 224.114% |
| Seer, Inc. | 7.02 Million USD | 1938.637% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 3051.142% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 699.68% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -108938.661% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -90060.571% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 21315.271% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 207.244% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 141.19% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -2583920.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 5119.464% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -254533.425% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 539.654% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -55590.086% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -26160.366% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1720.245% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -27126.29% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1242217.308% |
| Soligenix, Inc. | 97.31 Thousand USD | 132871.218% |
| Century Therapeutics, Inc. | -10.8 Million USD | -1095.309% |
| Kura Oncology, Inc. | -849 Thousand USD | -15118.021% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -92.538% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -87791.837% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 230.455% |
| Autolus Therapeutics plc | -4.86 Million USD | -2554.633% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 412.185% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -76805.357% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 236.399% |
| GRI Bio, Inc. | 10.84 Million USD | 1291.781% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 5186.682% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1387.291% |
| IGM Biosciences, Inc. | -211.66 Million USD | 38.958% |
| INmune Bio, Inc. | 155 Thousand USD | 83455.484% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 308.594% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -8477.426% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -19824.467% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -441250.687% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 32239.552% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -6372.996% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -41178.275% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 236.777% |
| Verastem, Inc. | -62 Thousand USD | -208288.71% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 5405.996% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -49402.299% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 4368.285% |
| Histogen Inc. | 3.76 Million USD | 3527.992% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 22523.761% |
| Surrozen, Inc. | -27.23 Million USD | -374.48% |
| Organovo Holdings, Inc. | -5.38 Million USD | -2297.495% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -10623.143% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -403.767% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 744.33% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -6525203.03% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 2229.772% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -192361.009% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 183.468% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 88715.226% |
| Apollomics, Inc. | 127 Thousand USD | 101833.071% |
| Amarin Corporation plc | 165.54 Million USD | 178.048% |
| Mesoblast Limited | -9.81 Million USD | -1216.363% |
| Turnstone Biologics Corp. | 16.5 Million USD | 882.752% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -16.936% |
| Synaptogenix, Inc. | -6347.00 USD | -2035523.129% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -253235.294% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 180.068% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 107.351% |
| Better Therapeutics, Inc. | -2.72 Million USD | -4634.372% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -15.192% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 138.216% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1132447.335% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1963.914% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -11560.74% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1865.523% |
| Insmed Incorporated | 239.63 Million USD | 153.916% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 3710.984% |
| OmniAb, Inc. | 14.66 Million USD | 980.896% |
| Alector, Inc. | -95.05 Million USD | -35.925% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 202.85% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -197.267% |
| Zai Lab Limited | 170.9 Million USD | 175.599% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 257.799% |
| Aura Biosciences, Inc. | -1.29 Million USD | -9876.911% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 99485.385% |
| Immunic, Inc. | -111 Thousand USD | -116297.297% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 914.943% |
| Veracyte, Inc. | 248.14 Million USD | 152.066% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.151% |
| FibroGen, Inc. | 128.9 Million USD | 200.23% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -22907878.723% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -1007.416% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 103.802% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 33313.625% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 136.359% |
| TG Therapeutics, Inc. | 219.1 Million USD | 158.967% |
| Galecto, Inc. | -830 Thousand USD | -15466.386% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -9228.592% |
| Fortrea Holdings Inc. | 424 Million USD | 130.472% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -49.943% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -22686.772% |
| XBiotech Inc. | -1.74 Million USD | -7308.314% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -11560.74% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -178.025% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -71.05% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 276.016% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 868.916% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 133.21% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -160.239% |
| Vaxxinity, Inc. | -2.23 Million USD | -5683.393% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 139.541% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -1040.964% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 628.408% |
| NexImmune, Inc. | -1.02 Million USD | -12505.32% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 2392711.111% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1718.284% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 101.143% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -193236.526% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -3538.44% |
| Ainos, Inc. | -253.73 Thousand USD | -50820.062% |
| Pluri Inc. | 322 Thousand USD | 40224.534% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 356.229% |
| Celularity Inc. | 6.75 Million USD | 2012.672% |
| Rallybio Corporation | -150 Thousand USD | -86034.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | -296.237% |
| MeiraGTx Holdings plc | 287 Thousand USD | 45117.77% |
| Omeros Corporation | -69.77 Million USD | -85.157% |
| Humacyte, Inc. | -76.55 Million USD | -68.78% |
| Immunocore Holdings plc | 248.39 Million USD | 152.015% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -751.744% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 307.113% |
| Blueprint Medicines Corporation | 236.58 Million USD | 154.611% |
| CalciMedica, Inc. | -58 Thousand USD | -222660.345% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -8960.379% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 544.677% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -4442.932% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -318.6% |
| Pulmatrix, Inc. | -8.22 Million USD | -1471.788% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -10942.821% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -32281.203% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 67.602% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 4754.911% |
| Cytokinetics, Incorporated | -322.59 Million USD | 59.949% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 15086.69% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -37788.856% |
| Vor Biopharma Inc. | -3.49 Million USD | -3599.914% |
| Roivant Sciences Ltd. | 109.23 Million USD | 218.278% |
| Evogene Ltd. | 1.39 Million USD | 9335.239% |
| ProKidney Corp. | -3.16 Million USD | -3977.027% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -194.227% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1984.221% |
| CorMedix Inc. | -205.56 Thousand USD | -62752.57% |
| BioLineRx Ltd. | 1.1 Million USD | 11760.74% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -64.23% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -391418.182% |
| Atai Life Sciences N.V. | -5000.00 USD | -2583920.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -105924.996% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -134484.375% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -9201.728% |
| Sagimet Biosciences Inc. | 2 Million USD | 6560.05% |
| MediciNova, Inc. | 979.7 Thousand USD | 13287.745% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -53.229% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -136541.108% |
| GeoVax Labs, Inc. | -20.72 Million USD | -523.534% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 152.835% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2975.482% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 114.811% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1839.846% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -41577.742% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -1076575.0% |
| Absci Corporation | -41.84 Million USD | -208.731% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2583920.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -69.171% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -5149.939% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 160.449% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -13630.181% |
| Allakos Inc. | -6.14 Million USD | -2003.908% |
| Imunon, Inc. | -720 Thousand USD | -17844.459% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -87.259% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 127.149% |
| BioAtla, Inc. | -103.73 Million USD | -24.554% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1132447.335% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -72484.831% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 46.791% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -41443.73% |
| XOMA Corporation | 3.86 Million USD | 3446.309% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -84.349% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 973.334% |
| aTyr Pharma, Inc. | -2.38 Million USD | -5310.427% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 1136.926% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -445420.69% |
| Viridian Therapeutics, Inc. | -1 Million USD | -12717.56% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 993853946.154% |
| Akari Therapeutics, Plc | -4000.00 USD | -3229925.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 120.286% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 66456.287% |
| UroGen Pharma Ltd. | 73.35 Million USD | 276.138% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -384.008% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 1112942.377% |
| Orgenesis Inc. | -5.72 Million USD | -2156.786% |
| Entera Bio Ltd. | -56 Thousand USD | -230616.071% |
| GH Research PLC | -315 Thousand USD | -40916.19% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -68260.317% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -24509.714% |
| Xencor, Inc. | -85.26 Million USD | -51.538% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -58368.076% |
| Replimune Group, Inc. | -2.65 Million USD | -4766.328% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -12804.15% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 172.649% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 66456.287% |
| Portage Biotech Inc. | -54 Thousand USD | -239161.111% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -136541.108% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -34170.822% |
| OncoCyte Corporation | 413 Thousand USD | 31383.535% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -2874227.03% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -58198548.649% |
| Purple Biotech Ltd. | -196 Thousand USD | -65818.878% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1540.689% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1420.804% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -1136.97% |
| HilleVax, Inc. | -2.15 Million USD | -5892.625% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -133096.907% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -861010.371% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -19241.467% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -561643.478% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1721166.267% |
| Savara Inc. | -44.26 Million USD | -191.901% |
| Curis, Inc. | 9.81 Million USD | 1416.899% |
| Daré Bioscience, Inc. | 2.76 Million USD | 4765.101% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -103436.398% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -7372.585% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -56567.105% |
| BeiGene, Ltd. | 2.07 Billion USD | 106.215% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -4521.088% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 67.673% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 327.916% |
| Erasca, Inc. | -3.73 Million USD | -3361.977% |
| bluebird bio, Inc. | -4.03 Million USD | -3105.98% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -457767.319% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 106.784% |
| DBV Technologies S.A. | 15.72 Million USD | 921.471% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -457767.319% |
| Moderna, Inc. | 2.15 Billion USD | 105.995% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -14020.328% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1713.802% |
| Molecular Templates, Inc. | 50.39 Million USD | 356.377% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -24004.664% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 196.571% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1976.519% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -228.396% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -16.263% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -3500.92% |
| MacroGenics, Inc. | 50.52 Million USD | 355.707% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -2018.744% |
| Prime Medicine, Inc. | -147.9 Million USD | 12.646% |
| Aditxt, Inc. | -111.66 Thousand USD | -115609.296% |
| Adagene Inc. | 18.11 Million USD | 813.365% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 26575.615% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 192.153% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 181.858% |
| SciSparc Ltd. | 2.19 Million USD | 5983.47% |
| Vericel Corporation | 135.57 Million USD | 195.298% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -515693.046% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -416919.56% |
| Generation Bio Co. | -73.91 Million USD | -74.806% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -29465.446% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 336.55% |
| Invivyd, Inc. | -2.02 Million USD | -6270.858% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 57.053% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -124806.707% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 234.07% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 231.451% |
| ADMA Biologics, Inc. | 88.21 Million USD | 246.457% |
| Clene Inc. | 533 Thousand USD | 24340.338% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 635.9% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -13400.627% |
| GeoVax Labs, Inc. | -20.72 Million USD | -523.534% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 6599.044% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -66390.15% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 359.414% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1721.785% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -15354.665% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 254.889% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 176816.544% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 343.033% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 25.398% |
| Trevena, Inc. | 1.45 Million USD | 8979.794% |
| Surrozen, Inc. | -27.23 Million USD | -374.48% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -36500.85% |
| Cingulate Inc. | -582.91 Thousand USD | -22064.524% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -416677.419% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -555.876% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1706650.33% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -14565.267% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 118.98% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -12977.024% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -229215.608% |
| Kronos Bio, Inc. | 1.37 Million USD | 9516.983% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -140.75% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -44146.918% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -26358.59% |
| ImmunityBio, Inc. | -17.89 Million USD | -622.197% |
| Korro Bio, Inc. | -3.63 Million USD | -3459.256% |
| Kineta, Inc. | 5.43 Million USD | 2478.078% |
| BioVie Inc. | -229.37 Thousand USD | -56226.92% |
| Codexis, Inc. | 57.33 Million USD | 325.348% |
| Celularity Inc. | 6.75 Million USD | 2012.672% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 3319.561% |
| Celcuity Inc. | -142.77 Thousand USD | -90394.635% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 255488.417% |
| Cibus, Inc. | 1.42 Million USD | 9185.865% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -34445.722% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -463.729% |
| IN8bio, Inc. | -2.5 Million USD | -5065.974% |
| Kodiak Sciences Inc. | -25.94 Million USD | -397.942% |
| Annexon, Inc. | -3.26 Million USD | -3854.729% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -6220.988% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -209.56% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 20287.656% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 116.596% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 174.702% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -6700.053% |
| Arcellx, Inc. | 108.27 Million USD | 219.322% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -299.15% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 263.124% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -510.822% |
| Moolec Science SA | -143.3 Thousand USD | -90058.054% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -205.31% |
| Geron Corporation | -123.5 Million USD | -4.614% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 4030.666% |
| Royalty Pharma plc | 1.79 Billion USD | 107.202% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -84.336% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -3576893.355% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 55936.657% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -15.965% |
| Humacyte, Inc. | -76.55 Million USD | -68.78% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -13511.94% |
| 89bio, Inc. | -273 Thousand USD | -47226.374% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -10178.52% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -15135.967% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -104941.463% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 11646.113% |
| Notable Labs, Ltd. | 113 Thousand USD | 114437.168% |
| Liquidia Corporation | 14.6 Million USD | 984.938% |
| Mustang Bio, Inc. | -2.22 Million USD | -5706.787% |
| Immunovant, Inc. | -231 Thousand USD | -55831.169% |
| Quantum-Si incorporated | 488 Thousand USD | 26575.615% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -132.547% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -430570.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 7038.829% |
| Acasti Pharma Inc. | -11 Thousand USD | -1174454.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -63042.847% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -19824.467% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 22.871% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 11487.562% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -33811.024% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -6498.621% |
| PepGen Inc. | -1.18 Million USD | -10812.247% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -101633.071% |
| United Therapeutics Corporation | 2.07 Billion USD | 106.242% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -464.27% |
| Solid Biosciences Inc. | -76.56 Million USD | -68.751% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -156349.875% |
| Immuneering Corporation | -764.13 Thousand USD | -16808.072% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 195079.174% |
| Belite Bio, Inc | -399 Thousand USD | -32281.203% |
| XOMA Corporation | 3.86 Million USD | 3446.309% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -544.844% |
| Bionomics Limited | -434.44 Thousand USD | -29639.049% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -11929.888% |
| uniQure N.V. | 2.21 Million USD | 5933.002% |
| Cassava Sciences, Inc. | -89.42 Million USD | -44.483% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -40.331% |
| Forte Biosciences, Inc. | -9000.00 USD | -1435466.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -15373.174% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -29465.446% |
| Altimmune, Inc. | -65.37 Million USD | -97.637% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 135.688% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -11929.888% |
| Compugen Ltd. | 31.45 Million USD | 510.749% |
| Peak Bio, Inc. | 367.76 Thousand USD | 35231.02% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 627.007% |
| Benitec Biopharma Inc. | 108 Thousand USD | 119730.556% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -165542.308% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -10639.9% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -6991.164% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -108472.269% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -10639.9% |
| Instil Bio, Inc. | -4.75 Million USD | -2616.59% |
| argenx SE | 1.1 Billion USD | 111.656% |
| Immunome, Inc. | -8.9 Million USD | -1350.556% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -6736.032% |
| Verona Pharma plc | -679.62 Thousand USD | -18910.659% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -73729.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | -5317.233% |
| CervoMed Inc. | -1.29 Million USD | -9887.5% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -5267.719% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -2604.647% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 5328.693% |
| Moolec Science SA | -143.3 Thousand USD | -90058.054% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -31564.583% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -4736.221% |
| AnaptysBio, Inc. | 14.78 Million USD | 974.102% |
| Design Therapeutics, Inc. | -537 Thousand USD | -23959.777% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -30157.845% |
| NeurAxis, Inc. | 2.15 Million USD | 6090.669% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 6120.55% |
| Lumos Pharma, Inc. | 2 Million USD | 6537.519% |
| Achilles Therapeutics plc | -4.73 Million USD | -2630.791% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -73729.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -122162.598% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 508.105% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 15086.69% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -12419.477% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -183.659% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 300567.442% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -15617.883% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -981819.745% |
| Palisade Bio, Inc. | 246 Thousand USD | 52620.732% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -391418.182% |
| Beam Therapeutics Inc. | -59.67 Million USD | -116.519% |
| Neurogene Inc. | -3.26 Million USD | -3860.791% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 192.727% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -3399.485% |
| Sesen Bio, Inc. | 40 Million USD | 423.003% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -43402.02% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -3108.339% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1250.627% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 1017.621% |
| Athira Pharma, Inc. | -969 Thousand USD | -13233.437% |
| Vaccinex, Inc. | -16 Million USD | -707.304% |
| HCW Biologics Inc. | -574.82 Thousand USD | -22376.619% |
| XOMA Corporation | 3.86 Million USD | 3446.309% |
| Nektar Therapeutics | 53.47 Million USD | 341.597% |
| Arvinas, Inc. | 71.8 Million USD | 279.946% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -54.804% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -105.816% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -40024.534% |
| Rezolute, Inc. | -36 Thousand USD | -358791.667% |
| Clene Inc. | 533 Thousand USD | 24340.338% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -10062283.178% |
| BeyondSpring Inc. | 1.75 Million USD | 7478.698% |
| Synlogic, Inc. | -1.92 Million USD | -6615.229% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -349091.892% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1940.445% |
| Peak Bio, Inc. | 367.76 Thousand USD | 35231.02% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -581.332% |
| Krystal Biotech, Inc. | 47.6 Million USD | 371.402% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 191.573% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 2671.164% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -4889.96% |
| MannKind Corporation | 136.19 Million USD | 194.868% |
| Ikena Oncology, Inc. | -50.49 Million USD | -155.884% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 218.736% |
| Gossamer Bio, Inc. | -4.38 Million USD | -2846.431% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -51170.238% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2583920.0% |
| Legend Biotech Corporation | 140.92 Million USD | 191.678% |
| Mural Oncology plc | -2.56 Million USD | -4933.152% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -23348.457% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -129101.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 722.535% |
| REGENXBIO Inc. | 53.02 Million USD | 343.642% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -2311.837% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -67061.014% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -7359.642% |
| Vaxart, Inc. | -60.76 Million USD | -112.631% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -49066.984% |
| Cellectis S.A. | 18 Thousand USD | 717883.333% |
| Longeveron Inc. | 221 Thousand USD | 58561.991% |
| Repare Therapeutics Inc. | -80.07 Million USD | -61.36% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 111.821% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -9884.621% |
| Revolution Medicines, Inc. | -399.66 Million USD | 67.673% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -369045.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 263775.51% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.501% |
| Denali Therapeutics Inc. | -93.34 Million USD | -38.412% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -515693.046% |
| Veru Inc. | 7.56 Million USD | 1807.669% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -85463.576% |
| Cingulate Inc. | -582.91 Thousand USD | -22064.524% |
| Passage Bio, Inc. | -3.72 Million USD | -3372.212% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -1072641.614% |
| Exicure, Inc. | -1.42 Million USD | -8979.48% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -33633.943% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 4879.911% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -25101.346% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 289.65% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -86260.264% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -118.223% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 33143.734% |
| OmniAb, Inc. | 14.66 Million USD | 980.896% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 746.231% |
| Lipocine Inc. | -2.85 Million USD | -4432.068% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -6910.364% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -2164.698% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -8477.426% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 271.545% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -198670.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 253.271% |
| Ocugen, Inc. | -33.53 Million USD | -285.249% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -3986.053% |
| Q32 Bio Inc. | 578 Thousand USD | 22453.114% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -48655.094% |
| Alumis Inc. Common Stock | -1.28 Million USD | -9962.383% |
| Equillium, Inc. | 35.95 Million USD | 459.311% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -7468.893% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 25905.157% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -3125226.56% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -49784.556% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 30664.782% |
| Dominari Holdings Inc. | 2.03 Million USD | 6436.488% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -70320.393% |
| vTv Therapeutics Inc. | -13.59 Million USD | -850.357% |
| Bio-Techne Corporation | 773.07 Million USD | 116.713% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 846.007% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 128.039% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -10952.267% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -438.786% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1204.565% |
| Nkarta, Inc. | -5.86 Million USD | -2101.414% |
| BioCardia, Inc. | -7.24 Million USD | -1682.329% |
| Iterum Therapeutics plc | -1.75 Million USD | -7282.914% |